Jon Barnett

No ORCID on file · 2 papers in corpus

2026

Assessment of endometriosis angiogenesis using 99mTc-maraciclatide imaging (DETECT): a single-centre, exploratory, open-label, non-randomised, phase 2 study

·doi:10.1016/s3050-5038(26)00048-8

Background Novel non-invasive or minimally invasive diagnostic tests for endometriosis are a research priority. Superficial peritoneal endometriosis, the most prevalent subtype of endometriosis (80% of all laparoscopically diagnosed disease…

rct 2024

Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99m Tc-maraciclatide in healthy volunteers

Nuclear medicine communications ·doi:10.1097/mnm.0000000000001814

BACKGROUND: 99m Tc-Maraciclatide is a radiolabelled RGD (Arg-Gly-Asp) peptide that binds with high affinity to α v β 3 and α v β 5 integrins, common receptors upregulated in disease states involving angiogenesis and inflammation. As such, i…